Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
14.27%
Operating Margin
14.61%
Net Margin
9.77%
Efficiency Metrics
Revenue per Expense Ratio
1.17
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
23.19%
Income Tax Rate
38.21%
EPS
8.8500000000
Balance Sheet Analysis
Current Ratio
1.12
Cash Ratio
0.38
Working Capital
$10.74B
Debt to Equity
0.43
Debt to Assets
17.65%
Equity Ratio
41.16%
Cash Flow Analysis
Operating Cash Flow Ratio
18.58%
Free Cash Flow Ratio
10.49%
CapEx to Revenue
8.09%
Dividends Paid
$7.52B
Stock Buybacks
$9.17B
Total Shareholder Returns
$16.68B
Cash Position Change
-17.45%
Key Takeaways (2023 FY)
Revenue declined by 16.848961300368%, indicating potential market challenges
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
-16.85%
Net Income
4.18%
EPS
10.21%
Operating Income
-29.97%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
-354.01%
Operating Cash Flow
-14.12%
Free Cash Flow
-27.53%
Balance Sheet Health
Assets
-6.65%
Debt
-21.22%
Book Value per Share
10.19%
Inventory
-15.78%
Shareholder Returns
Dividends per Share
-20.45%
Shares Outstanding
-5.38%
Long Term Trends
3Y Revenue/Share
96.88%
5Y Revenue/Share
28.28%
3Y Dividend/Share
20.98%
5Y Dividend/Share
65.03%